A detailed history of Anchor Investment Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Anchor Investment Management, LLC holds 36,724 shares of EW stock, worth $2.71 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
36,724
Previous 38,035 3.45%
Holding current value
$2.71 Million
Previous $3.51 Billion 31.02%
% of portfolio
0.23%
Previous 0.36%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

SELL
$59.7 - $93.78 $78,266 - $122,945
-1,311 Reduced 3.45%
36,724 $2.42 Billion
Q2 2024

Sep 20, 2024

SELL
$84.3 - $94.31 $67,440 - $75,448
-800 Reduced 2.06%
38,035 $3.51 Billion
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $47,078 - $62,018
649 Added 1.7%
38,835 $3.71 Billion
Q4 2023

Jan 02, 2024

BUY
$61.71 - $77.76 $2.36 Million - $2.97 Million
38,186 New
38,186 $2.91 Billion
Q3 2023

Jan 02, 2024

BUY
$69.28 - $93.38 $13,232 - $17,835
191 Added 0.66%
29,026 $2.01 Billion
Q2 2023

Jan 02, 2024

SELL
$81.41 - $94.33 $244,962 - $283,838
-3,009 Reduced 9.45%
28,835 $2.72 Billion
Q1 2023

Jan 02, 2024

BUY
$74.26 - $84.51 $33,788 - $38,452
455 Added 1.45%
31,844 $2.63 Billion
Q4 2022

Jan 02, 2024

SELL
$68.3 - $87.44 $464,235 - $594,329
-6,797 Reduced 17.8%
31,389 $2.34 Billion
Q3 2022

Jan 02, 2024

SELL
$82.37 - $107.29 $656,983 - $855,745
-7,976 Reduced 20.89%
30,210 $2.5 Billion
Q2 2022

Jan 02, 2024

BUY
$86.5 - $128.27 $692 - $1,026
8 Added 0.03%
31,512 $3 Billion
Q1 2022

Jan 02, 2024

BUY
$101.96 - $128.34 $46,187 - $58,138
453 Added 1.46%
31,504 $3.71 Billion
Q4 2021

Jan 02, 2024

BUY
$106.37 - $130.68 $8,722 - $10,715
82 Added 0.26%
31,051 $4.02 Billion
Q3 2021

Jan 02, 2024

SELL
$102.91 - $122.75 $742,701 - $885,886
-7,217 Reduced 18.9%
30,969 $3.51 Billion
Q2 2021

Jan 02, 2024

SELL
$83.84 - $104.76 $49,465 - $61,808
-590 Reduced 1.83%
31,721 $3.29 Billion
Q1 2021

Jan 02, 2024

BUY
$78.68 - $90.67 $425,422 - $490,252
5,407 Added 20.1%
32,311 $2.7 Billion
Q4 2020

Jan 02, 2024

BUY
$71.69 - $91.23 $178,077 - $226,615
2,484 Added 10.17%
26,904 $2.45 Billion
Q3 2020

Jan 02, 2024

SELL
$67.19 - $87.44 $924,937 - $1.2 Million
-13,766 Reduced 36.05%
24,420 $1.95 Billion
Q2 2020

Jan 02, 2024

BUY
$57.54 - $76.95 $869,717 - $1.16 Million
15,115 Added 193.46%
22,928 $1.58 Billion
Q1 2020

Jan 02, 2024

BUY
$52.41 - $81.0 $32,179 - $49,734
614 Added 8.53%
7,813 $1.47 Billion
Q4 2019

Jan 02, 2024

BUY
$71.7 - $82.09 $64,601 - $73,963
901 Added 14.31%
7,199 $1.68 Billion
Q3 2019

Jan 02, 2024

SELL
$61.55 - $75.43 $1.96 Million - $2.41 Million
-31,888 Reduced 83.51%
6,298 $1.38 Billion
Q2 2019

Jan 02, 2024

BUY
$55.74 - $64.41 $8,639 - $9,983
155 Added 2.55%
6,228 $1.15 Billion
Q1 2019

Jan 02, 2024

BUY
$47.89 - $64.05 $51,960 - $69,494
1,085 Added 21.75%
6,073 $1.16 Billion
Q4 2018

Jan 02, 2024

SELL
$46.41 - $56.94 $1,160 - $1,423
-25 Reduced 0.5%
4,988 $764 Million
Q3 2018

Jan 02, 2024

SELL
$45.7 - $58.03 $1.52 Million - $1.93 Million
-33,173 Reduced 86.87%
5,013 $873 Million
Q2 2018

Jan 03, 2024

SELL
$42.45 - $51.3 $1.38 Million - $1.66 Million
-32,405 Reduced 84.86%
5,781 $842 Million
Q1 2018

Jan 03, 2024

BUY
$37.19 - $47.45 $1,264 - $1,613
34 Added 0.6%
5,723 $798 Million
Q4 2017

Jan 03, 2024

BUY
$33.79 - $39.39 $19,564 - $22,806
579 Added 11.33%
5,689 $641 Million
Q3 2017

Jan 03, 2024

BUY
$36.29 - $38.83 $1,270 - $1,359
35 Added 0.69%
5,110 $559 Million
Q2 2017

Jan 03, 2024

SELL
N/A
-33,111 Reduced 86.71%
5,075 $600 Million
Q1 2017

Jan 03, 2024

SELL
N/A
-85 Reduced 1.67%
5,005 $471 Million
Q4 2016

Jan 03, 2024

SELL
N/A
-65 Reduced 1.26%
5,090 $477 Million
Q3 2016

Jan 03, 2024

BUY
N/A
85 Added 1.68%
5,155 $621 Million
Q2 2016

Jan 03, 2024

SELL
N/A
-33,116 Reduced 86.72%
5,070 $506 Million
Q1 2016

Jan 03, 2024

SELL
N/A
-34,616
3,570 $315 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.